临床试验/NCT03064282

NCT03064282Unknown早期 1 期

Treatment of Prostatic Hyperplasia With Topical Papaverine

Manchanda Medical Clinic0 个研究点目标入组 40 人开始时间: 2021年6月30日最近更新: 2021年2月25日

适应症

干预措施

相关药物

试验速览

阶段: 早期 1 期
发起方: Manchanda Medical Clinic
入组人数: 40
主要终点: Laboratory tests to measure regression of symptoms

研究概览研究设计入排标准研究组 & 干预措施结局指标研究者记录与标识符相似试验

研究概览

简要总结

Treatment of patients with prostatic hyperplasia with topical papaverine.

详细描述

Patients with obstructive voiding and high PSA to be studied for the regression of symptoms and declining PSA.

研究设计

研究类型: Interventional
分配方式: Non Randomized
干预模型: Parallel
主要目的: Treatment
盲法: None

入排标准

年龄范围: 50 Years 至 70 Years（Adult, Older Adult）
性别: Male
接受健康志愿者: 是

入选标准

•patients with symptoms e.g. obstructive voiding, hyperplasia and high PSA

排除标准

•patients on chemotherapy
•abnormal lab values e.g. liver function, GFR and CAD

研究组 & 干预措施

Placebo

Placebo Comparator

Drug free base as placebo

干预措施: Placebo (Other)

group two- papaverine arm

Experimental

papaverine in a suitable base

干预措施: papaverine (Drug)

结局指标

主要结局

Laboratory tests to measure regression of symptoms

时间窗: every 4 weeks up to 16 weeks

patients follow-up on regular intervals

次要结局

未报告次要终点

研究者

发起方

Manchanda Medical Clinic

申办方类型

Other

责任方

Principal Investigator

主要研究者

DR. VINOD C TAWAR

Principal Investigator

Manchanda Medical Clinic

相似试验

Cetrorelix Pamoate IM Regimens in Patients With Symptomatic Benign Prostatic Hyperplasia (BPH)Benign Prostatic Hypertrophy

NCT00670306AEterna Zentaris528

On Label, Randomized, Double-Blind, Placebo-Controlled Trial of Preoperative Finasteride in Patients Undergoing Transurethral Resection of the Prostate (TURP)Benign Prostatic Hyperplasia

NCT00564460University of Alberta

Intracavernosal Injection of Papaverine/Verapamil Versus Papaverine/Phentolamine in Erectile DysfunctionErectile Dysfunction

NCT03033537Adam International Hospital20

Saw Palmetto Extract in Benign Prostatic HyperplasiaBenign Prostatic Hyperplasia

NCT00037154National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)224

Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic HyperplasiaBenign Prostatic Hyperplasia

NCT01789840Merit Medical Systems, Inc.59